A novel mutation in KCNA1 causes episodic ataxia without myokymia

H Lee, H Wang, JC Jen, C Sabatti, RW Baloh… - Human …, 2004 - Wiley Online Library
H Lee, H Wang, JC Jen, C Sabatti, RW Baloh, SF Nelson
Human mutation, 2004Wiley Online Library
We describe a unique family in which several individual are affected with episodes of ataxia
that best fit the phenotype of episodic ataxia type 2 (EA2). All of the affected family members
had episodes typically lasting for several hours, and none of them had muscle abnormalities
including myokymia. Episodic ataxia type 1 (EA1) was not considered initially as a clinical
diagnosis for the affected individuals in this family. However, by linkage mapping,
sequencing and polymorphism analysis, all affecteds were found to have a novel mutation in …
Abstract
We describe a unique family in which several individual are affected with episodes of ataxia that best fit the phenotype of episodic ataxia type 2 (EA2). All of the affected family members had episodes typically lasting for several hours, and none of them had muscle abnormalities including myokymia. Episodic ataxia type 1 (EA1) was not considered initially as a clinical diagnosis for the affected individuals in this family. However, by linkage mapping, sequencing and polymorphism analysis, all affecteds were found to have a novel mutation in KCNA1. Numerous missense mutations have been described previously in KCNA1 that cause EA1. The mutation c.1025G>T replaces a highly conserved serine with isoleucine at position 342 (p.Ser342Ile) in the highly conserved fifth transmembrane domain of the KCNA1. This mutation leads to a distinct clinical phenotype without myokymia broadening the scope of clinical characteristics of EA1 and highlighting the heterogeneity of phenotypic effects from distinct missense mutations. © 2004 Wiley‐Liss, Inc.
Wiley Online Library